SG Americas Securities’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-23,756
Closed -$48K 3245
2022
Q1
$48K Sell
23,756
-11,653
-33% -$23.5K ﹤0.01% 2505
2021
Q4
$96K Sell
35,409
-35,941
-50% -$97.4K ﹤0.01% 2794
2021
Q3
$318K Buy
71,350
+52,271
+274% +$233K ﹤0.01% 2654
2021
Q2
$111K Sell
19,079
-61,450
-76% -$358K ﹤0.01% 2364
2021
Q1
$565K Buy
80,529
+40,184
+100% +$282K ﹤0.01% 1763
2020
Q4
$194K Sell
40,345
-108,831
-73% -$523K ﹤0.01% 2327
2020
Q3
$870K Sell
149,176
-53,016
-26% -$309K 0.01% 1054
2020
Q2
$1.37M Sell
202,192
-397,222
-66% -$2.68M 0.01% 916
2020
Q1
$3.81M Buy
+599,414
New +$3.81M 0.04% 363
2019
Q4
Sell
-47,027
Closed -$185K 2868
2019
Q3
$185K Sell
47,027
-42,526
-47% -$167K ﹤0.01% 2054
2019
Q2
$1.33M Sell
89,553
-7,595
-8% -$113K 0.01% 1138
2019
Q1
$2.41M Buy
97,148
+51,947
+115% +$1.29M 0.02% 663
2018
Q4
$812K Buy
+45,201
New +$812K 0.01% 1300
2018
Q3
Sell
-2,705
Closed -$123K 2956
2018
Q2
$123K Sell
2,705
-10,269
-79% -$467K ﹤0.01% 2565
2018
Q1
$685K Buy
12,974
+6,499
+100% +$343K 0.01% 1436
2017
Q4
$440K Buy
6,475
+1,010
+18% +$68.6K ﹤0.01% 1646
2017
Q3
$450K Sell
5,465
-13,848
-72% -$1.14M ﹤0.01% 1679
2017
Q2
$1.81M Buy
19,313
+14,520
+303% +$1.36M 0.02% 873
2017
Q1
$305K Sell
4,793
-22,422
-82% -$1.43M ﹤0.01% 1933
2016
Q4
$1.21M Buy
+27,215
New +$1.21M 0.01% 1094
2016
Q2
Sell
-6,719
Closed -$129K 2569
2016
Q1
$129K Buy
+6,719
New +$129K ﹤0.01% 2169
2015
Q4
Sell
-6,981
Closed -$642K 2536
2015
Q3
$642K Buy
6,981
+3,542
+103% +$326K ﹤0.01% 991
2015
Q2
$302K Sell
3,439
-5,620
-62% -$494K ﹤0.01% 1532
2015
Q1
$672K Buy
9,059
+4,624
+104% +$343K ﹤0.01% 1180
2014
Q4
$248K Buy
4,435
+1,923
+77% +$108K ﹤0.01% 2003
2014
Q3
$114K Sell
2,512
-2,886
-53% -$131K ﹤0.01% 1989
2014
Q2
$224K Buy
+5,398
New +$224K ﹤0.01% 1744
2013
Q4
Sell
-2,873
Closed -$175K 2615
2013
Q3
$175K Buy
+2,873
New +$175K ﹤0.01% 2008